Eisler Capital (Uk) Ltd. Merck & Co., Inc. Put Options Transaction History

Eisler Capital (Uk) Ltd.

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $16.6 Million - $19.3 Million	149,586 Added 30.32%	642,894 $73 Million
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $1.59 Million - $1.7 Million	-12,803 Reduced 2.53%	493,308 $61.1 Million
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $9.2 Million - $10.7 Million	81,240 Added 19.12%	506,111 $66.8 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $31.9 Million - $34.7 Million	318,230 Added 298.41%	424,871 $46.3 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $10.7 Million - $11.8 Million	103,641 Added 3454.7%	106,641 $11 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $325,830 - $355,140	3,000 New	3,000 $346,000
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $48.1 Million - $54.5 Million	-575,800 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $42.3 Million - $47.4 Million	575,800 New	575,800 $47.6 Million

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.